Dr. Irene Ghobrial, MD
Claim this profileDana Farber Cancer Institute
Affiliated Hospitals
Dana Farber Cancer Institute
Brigham And Women's Hospital
Clinical Trials Irene Ghobrial, MD is currently running
Blood Sample Analysis
for Multiple Myeloma
The PROMISE Study aims to establish a prospective cohort of individuals with precursor conditions to multiple myeloma, such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). We will study these patients as a means to identify risk factors for progression to symptomatic multiple myeloma.
Recruiting
1 award
N/A
3 criteria
Surveillance and Prevention
for Cancer Risk
This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or has been diagnosed with an early phase of a cancer or a family member who has a family member with a precursor condition for cancer. * The objective of this study is to identify exposures as well as clinical, molecular, and pathological changes that can be used to predict early development of cancer, malignant transformation, and risks of progression to symptomatic cancer that can ultimately be fatal. * The ultimate goal is to identify novel markers of early detection and risk stratification to drive potential therapeutic approaches to intercept progression to cancer.
Recruiting
1 award
N/A
10 criteria
More about Irene Ghobrial, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Irene Ghobrial, MD has experience with
- Dexamethasone
- Lenalidomide
- Daratumumab
- Teclistamab
- Ixazomib
- Ciltacabtagene Autoleucel
Breakdown of trials Irene Ghobrial, MD has run
Multiple Myeloma
Monoclonal Gammopathy
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Irene Ghobrial, MD specialize in?
Irene Ghobrial, MD focuses on Multiple Myeloma and Monoclonal Gammopathy. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Irene Ghobrial, MD currently recruiting for clinical trials?
Yes, Irene Ghobrial, MD is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Irene Ghobrial, MD has studied deeply?
Yes, Irene Ghobrial, MD has studied treatments such as Dexamethasone, Lenalidomide, Daratumumab.
What is the best way to schedule an appointment with Irene Ghobrial, MD?
Apply for one of the trials that Irene Ghobrial, MD is conducting.
What is the office address of Irene Ghobrial, MD?
The office of Irene Ghobrial, MD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.